Prevalence of exfoliation syndrome in central Sri Lanka: The Kandy eye study

British Journal of Ophthalmology

Volumn 92, Issue 12, 2008, Pages 1595-1598

  Rudkin, A K ^a   Edussuriya, K ^b   Sennanayake, S ^b   Senaratne, T ^b   Selva, D ^a   Sullivan, T R ^c   Casson, R J ^a  

^a South Australian Institute of Ophthalmology   (Australia)

^b Kandy Centre for Save Sight   (Sri Lanka)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLEPHRINE; TROPICAMIDE;

ADULT; AGED; AGING; ARTICLE; BIOMETRY; CATARACT; CLUSTER ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; EXFOLIATION SYNDROME; EYE EXAMINATION; FEMALE; GONIOSCOPY; HEALTH SURVEY; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SRI LANKA; UNIVARIATE ANALYSIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGE FACTORS; AGED; BIOMETRY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; PREVALENCE; RURAL HEALTH; SRI LANKA;

EID: 57149102138     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.146407     Document Type: Article

References (25)

1. Ringvold A. Epidemiology of the pseudo-exfoliation syndrome. Acta Ophthalmol Scand 1999;77:371-5.
2. Schlotzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006;141:921-37.
3. Grodum K, Heijl A, Bengtsson B. Risk of Glaucoma in ocular hypertension with and without pseudoexfoliation. Ophthalmology 2005;112:386-90.
4. Thorietfsson G, Magnusson KP, Sulem P. et al. Common sequence variants in the L0XL1 gene confer susceptibility to exfoliation glaucoma. Science 2007;317:1397-400.
5. Hewitt AW, Sharma S. Burdon KP, et al. Ancestral L0XL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet 2008;17:710-16.
6. Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: A compilation of population based prevalence studies. Ophthalmic Epidemiol 2004;11:67-115.
7. Arvind H, Raju P, Paul PG, et al. Pseudoexfoliation in South India. Br J Ophthalmol 2003;87:1321-3.
8. Thomas R, Nirmalan PK, Krishnaiah S. Pseudoexfoliation in southern India: the Andhra Pradesh Eye Disease Study. Invest Ophthalmol Vis Sci 2005;46:1170-6.
9. Krishnadas R, Nirmalan PK, Ramakrishnan R, et al. Pseudoexfoliation in a rural population of southern India: the Aravind Comprehensive Eye Survey. Am J Ophthalmol 2003;135:830-7.
10. Chytack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993;111:831-6.
11. Forsius H. Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos, and Russians. Trans Ophthalmol Soc UK 1979;99:296-8.
12. Foster PJ, Seah SK. The prevalence of pseudoexfoliation syndrome in Chinese people: the Tanjong Pagar Survey. Br J Ophthalmol 2005;89:239-40.
13. Young AL, Tang WW, Lam DS. The prevalence of pseudoexfoliation syndrome in Chinese people. Br J Ophthalmol 2004;88:193-5.
14. Hirvala M, Luukinen H, Laatikainen L. Prevalence and risk factors of lens opacities in the elderly in Finland. A population-based study. Ophthalmology 1995;102:108-17.
15. Puska P, Tarkkanen A. Exfoliation syndrome as a risk factor for cataract development: five-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg 2001;27:1992-8.
16. Hietanen J, Kivela T. Vesti E, et al. Exfoliation syndrome in patients scheduled for cataract surgery. Acta Ophthalmologica 1992;70:440-6.
17. Kaljurand K, Puska P. Exfoliation syndrome in Estonian patients scheduled for cataract surgery. Acta Ophthalmol Scand 2004;82:259-63.
18. Streeten BW, Li ZY. Wallace RN. et al. Pseudoexfoliative fibrillopathy in visceral organs of a patient with exfoliation syndrome. Arch Ophthalmol 1992;110:1757-62.
19. Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 1997;124:685-7.
20. Ritiand JS, Egge K, Lydersen S, et al. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand 2004;82:401-4.
21. Schumacher S, Schlotzer-Schrehardt U, Martus P, et al. Pseudoexfoliation syndrome and aneurisms of the abdominal aorta. Lancet 2001;357:359-60.
22. Allingham RR, Loftsdottir M, Gottfredsdottir MS, et al. Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol 2001;85:702-7.
23. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 1989;149:780-8.
24. Arnarsson A, Jonasson F, Sasaki H, et al. Reykjavik Eye Study Group. Risk factors for nuclear lens opacification: the Reykjavik Eye Study. Dev Ophthalmol 2002;35:12-20.
25. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20.